Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.

Shelton RC, Papakostas GI.

Acta Psychiatr Scand. 2008 Apr;117(4):253-9. doi: 10.1111/j.1600-0447.2007.01130.x. Epub 2008 Jan 8. Review.

PMID:
18190674
2.

Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.

Philip NS, Carpenter LL, Tyrka AR, Price LH.

J Psychiatr Pract. 2008 Jan;14(1):34-44. doi: 10.1097/01.pra.0000308493.93003.92. Review.

PMID:
18212601
3.

[Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].

Erbe S, Gutwinski S, Bschor T.

Psychiatr Prax. 2012 Mar;39(2):57-63. doi: 10.1055/s-0031-1277013. Epub 2011 Dec 21. Review. German.

PMID:
22189902
4.

Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.

Khouzam HR.

Postgrad Med. 2016;128(3):323-30. doi: 10.1080/00325481.2016.1147925. Epub 2016 Feb 16. Review.

PMID:
26821680
5.

Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.

Wen XJ, Wang LM, Liu ZL, Huang A, Liu YY, Hu JY.

Braz J Med Biol Res. 2014 Jul;47(7):605-16. Epub 2014 Jun 13. Review.

6.

The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting.

Kasckow JW, Mulchahey JJ, Mohamed S.

J Am Med Dir Assoc. 2004 Jul-Aug;5(4):242-8. Review.

PMID:
15228634
7.

Treatment of bipolar disorder: the evolving role of atypical antipsychotics.

Perlis RH.

Am J Manag Care. 2007 Nov;13(7 Suppl):S178-88. Review. Erratum in: Am J Manag Care. 2008 Feb;14(2):76.

PMID:
18041879
8.

Creating more effective antidepressants: clues from the clinic.

Rasmussen K.

Drug Discov Today. 2006 Jul;11(13-14):623-31. Review.

PMID:
16793531
9.

The case for atypical antipsychotics in bipolar disorder.

Shattell M, Keltner NL.

Perspect Psychiatr Care. 2004 Jan-Mar;40(1):34-8. Review.

PMID:
15147051
10.

Treatment of bipolar depression: making sensible decisions.

Citrome L.

CNS Spectr. 2014 Dec;19 Suppl 1:4-11; quiz 1-3, 12. doi: 10.1017/S109285291400056X. Epub 2014 Nov 19. Review.

PMID:
25407667
11.

Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.

Bobo WV, Shelton RC.

Expert Rev Neurother. 2010 May;10(5):651-70. doi: 10.1586/ern.10.44. Review.

PMID:
20420487
13.

Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder.

Blier P, Blondeau C.

J Affect Disord. 2011 Jan;128 Suppl 1:S3-10. doi: 10.1016/S0165-0327(11)70003-9. Review.

PMID:
21220079
14.

Use of atypical antipsychotics in mood disorders.

Weizman R, Weizman A.

Curr Opin Investig Drugs. 2001 Jul;2(7):940-5. Review.

PMID:
11757795
15.

Pharmacology of antipsychotics in the elderly: a focus on atypicals.

Finkel S.

J Am Geriatr Soc. 2004 Dec;52(12 Suppl):S258-65. Review. No abstract available.

PMID:
15541166
16.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
17.

Long-term use of atypical antipsychotics in bipolar disorder.

Ehret MJ, Levin GM.

Pharmacotherapy. 2006 Aug;26(8):1134-47. Review.

PMID:
16863489
18.

A typical mood stabilizers: a "typical role for atypical antipsychotics.

Malhi GS, Berk M, Bourin M, Ivanovski B, Dodd S, Lagopoulos J, Mitchell PB.

Acta Psychiatr Scand Suppl. 2005;(426):29-38. Review.

PMID:
16104066
19.

The treatment of mixed states and the risk of switching to depression.

Vieta E.

Eur Psychiatry. 2005 Mar;20(2):96-100. Review.

PMID:
15797692
20.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311

Supplemental Content

Support Center